Cogvio
Cogvio, an IQVIA business, is a Prague-based SaaS and consulting provider that builds AI-powered pricing, market access and market intelligence tools for large pharmaceutical companies, serving clients such as AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer.
- Company typePrivate
- Founded2017
- HeadquartersPrague, Czechia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Cogvio does
Cogvio (legal entity Cogvio, s.r.o.) is a Prague-headquartered technology and data science company that develops SaaS products and provides consulting services to the pharmaceutical and healthcare industries. It operates as a wholly-owned subsidiary of IQVIA (NYSE:IQV) and is commercially positioned as 'COGVIO, an IQVIA business.' The company's product portfolio is built around three core SaaS tools: Price Monitor, an AI-powered platform that continuously integrates pricing, reimbursement and health technology assessment (HTA) data from more than 100 global sources to support market access, payer negotiations and lifecycle price management; Market Access Monitor, which tracks market access conditions across geographies; and Market Intelligence Tool, which provides competitive and market intelligence for pharma decision-makers. Underlying technology uses AI-powered algorithms for automatic data extraction, predictive analytics, optimization of launch and pricing strategies, and anomaly detection for price erosion control, complemented by custom analytics, real-world evidence (RWE) work, and integration with client data warehouses and BI systems.
Cogvio's commercial model combines annual subscription-based SaaS access to Price Monitor, Market Access Monitor and Market Intelligence Tool with a professional services arm that delivers custom consulting, audits, IT technology assessment, and GAMP/GDPR/HIPAA-compliant healthcare software development. Go-to-market is enterprise field sales targeting market access and pricing teams at large pharmaceutical companies; pricing is quote-based with no public tiers, and products are accessed via authenticated portals (pricemonitor.cogvio.com, login.cogvio.com, mit.cogvio.com). The named customer base includes seven top-tier pharmaceutical companies — AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer — alongside a secondary healthcare IT segment serving hospitals and other organizations needing regulatory-compliant software. Cogvio was founded in 2017 by Pavel Svítil (CEO), Tomáš Doležal (Chief Knowledge Officer) and Petr Bartoš (CTO), combines deep regulatory, medical, pharmacoeconomics and software expertise, and is currently sized at 11-50 employees operating globally with particular concentration in Europe.
Cogvio firmographics
Firmographics- Name
- Cogvio
- Legal name
- Cogvio, s.r.o.
- Website
- https://cogvio.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cogvio, an IQVIA business, is a Prague-based SaaS and consulting provider that builds AI-powered pricing, market access and market intelligence tools for large pharmaceutical companies, serving clients such as AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer.
- Ownership category
- akta.pro rank
Cogvio industry classification
Industry- Product category
- Pharmaceutical Market Access & Pricing Analytics
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Pricing Operations & Analytics (Price Governance, Systems, Reporting) (HLAIAKAK)
- akta.pro secondary industries
- International Reference Pricing (IRP) & External Price Benchmarking (HLAIAKAF), Pricing & Contracting Strategy (HLAIAKAA), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI)
Keywords
Where Cogvio is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices1 record
Markets served
Cogvio business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Products (SaaS): Subscription-based access to AI-powered software tools including Price Monitor, Market Access Monitor, and Market Intelligence Tool. These platforms provide continuous insights and analytics for pharmaceutical pricing and market access teams.
- Professional Services & Consulting: Custom consulting projects including tailor-made solutions, audits, IT technology assessment, and software development for pharma and healthcare clients. Cooperation model described as 'Be a partner, not a client.'
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise pricing via direct inquiry |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Cogvio product offering
Product offeringCore offering
Cogvio develops and sells AI-powered SaaS platforms—primarily Price Monitor—that aggregate over 100 global sources of drug pricing, reimbursement, and HTA data to deliver market access and pricing insights to pharmaceutical companies. Its offering is complemented by Market Access Monitor and Market Intelligence Tool, plus consulting and custom data analysis services for pharma and healthcare clients.
Product overview
COGVIO, an IQVIA business, is a technology start-up developing specialized software products and providing consulting to the pharma industry. The product portfolio centers on three main digital tools: Price Monitor (AI-powered pricing/reimbursement data platform integrating 100+ global sources), Market Access Monitor (market access monitoring), and Market Intelligence Tool (market intelligence). These are complemented by consulting services including drug pricing & market access strategies, advanced data analysis (custom projects, RWE analysis, data integration), and pharma/healthcare software development & compliance services.
Differentiator
Problem solved
Functional benefit
Brands
- Price Monitor: AI-powered digital tool that integrates 100+ global sources of pricing/reimbursement/HTA data and provides market access and pricing insights for pharmaceutical companies.
- Market Access Monitor
- Market Intelligence Tool
Quantifiable outcome
- AI-powered engine continuously integrating 100+ global data sources
Companies that use Cogvio
Customer profileNamed customers7 records
Segments2 records
Ideal customer profiles2 records
Cogvio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Cogvio partnerships and signals
Strategic signalScale indicators4 records
Recent moves7 records
Expansion highlights5 records
Cogvio competitors and assessment
Company assessmentEmerging players
- OptimizeRx: Digital health platform providing market access, affordability, and physician-engagement solutions to pharma. Comparable in targeting pharma market access teams with software-based solutions, though more focused on patient affordability.
- Definitive Healthcare: Healthcare commercial intelligence provider selling analytics on providers, payers, and biopharma to life sciences customers. Partial overlap with Cogvio on pharma market intelligence use cases, though broader in scope.
Broad incumbents
- Veeva Systems: Dominant cloud platform vendor for pharma commercial and R&D workflows, including CRM and data products. Adjacent/competing for the same market access and pricing IT wallet with broader product breadth.
- IQVIA: Parent company and global leader in healthcare intelligence, clinical research, and commercial analytics. Cogvio operates as 'an IQVIA business,' and IQVIA itself sells broader market access and pricing analytics solutions, making it the closest incumbent for comparability on category, customer base, and commercial reach.
- Clarivate (Decision Resources Group): Owns the former DRG market access and pricing intelligence franchise used by pharma for global pricing benchmarks, HTA, and forecasting. A direct competitor in international reference pricing and market access data, with broader portfolio scale.
Direct peers
- ZS Associates: Management consulting and analytics firm serving pharma with pricing, market access, and AI-driven commercial solutions. Comparable to Cogvio in domain specialization, enterprise pharma customers, and analytics-plus-services model.
- Charles River Associates: Life sciences consulting practice offering pricing, market access, and commercial analytics to pharma. Comparable to Cogvio on combining analytics, pricing expertise, and Big Pharma customer base.
- Trinity Life Sciences: Pharma strategy and analytics firm providing market access, pricing, and competitive intelligence to manufacturers. Comparable to Cogvio on customer base (Big Pharma) and on combining software-style insights with consulting services.
- EVERSANA: Specialty pharma commercial services firm offering pricing, market access, and data-driven launch solutions to manufacturers. Directly comparable to Cogvio's pricing/market access focus and enterprise pharma customer base, with both subscription software and consulting revenue streams.
Regional players
- Cencora (formerly AmerisourceBergen) / PharmaLex: Through PharmaLex and consulting arms, provides global market access, pricing, and regulatory services to pharma. Comparable in offering integrated market access and pricing expertise to manufacturers, with broader distribution/scale.
Market position
Strengths5 records
Weaknesses2 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Cogvio social profiles
Digital presenceCogvio compliance and trust
Trust signalCompliance3 records
Cogvio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cogvio leadership team
Management profileNumber of profiles
Profiles3 records
Cogvio funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cogvio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cogvio
What does Cogvio do?
Cogvio develops and sells AI-powered SaaS platforms—primarily Price Monitor—that aggregate over 100 global sources of drug pricing, reimbursement, and HTA data to deliver market access and pricing insights to pharmaceutical companies. Its offering is complemented by Market Access Monitor and Market Intelligence Tool, plus consulting and custom data analysis services for pharma and healthcare clients.
Is Cogvio a public or private company?
Cogvio is a private company. It is classified as corporate owned and is currently operating.
When was Cogvio founded?
Cogvio was founded in 2017. It employs 11 to 50 people.
Where is Cogvio based?
Cogvio is headquartered in Prague, Czechia, in the Europe region.
How does Cogvio make money?
Two revenue lines are on record. Software Products (SaaS) is the primary driver. The others are professional Services & Consulting.
Who are Cogvio's main competitors?
Emerging players on record are OptimizeRx and Definitive Healthcare. Broad incumbents are Veeva Systems, IQVIA and Clarivate (Decision Resources Group). Direct peers are ZS Associates, Charles River Associates, Trinity Life Sciences and EVERSANA. Cencora (formerly AmerisourceBergen) / PharmaLex is listed as a regional player.
Does Cogvio have an API?
No public API is recorded for Cogvio.
What industry is Cogvio in?
Cogvio's product category is Pharmaceutical Market Access & Pricing Analytics. Its primary akta.pro industry code is HLAIAKAK, Pricing Operations & Analytics (Price Governance, Systems, Reporting), with a secondary code of HLAIAKAF, International Reference Pricing (IRP) & External Price Benchmarking. Its NAICS code is 513210 and its SIC code is 7372.